Schedule 13G ownership disclosure

CEREBAIN BIOTECH CO XXXREGISTRATION REVOKED BY THE SEC EFF: 09/03/21

Security class unavailable · CUSIP: 15672M106

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
70,920,235
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-004597
Form type
SC 13G/A
Filer
CEREBAIN BIOTECH CORP.
CIK
CIK 1453099
Filed
Jan 27, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub